We are live on
!
Find out more
HMC
Harvard Management Company Portfolio holdings
AUM
$1.82B
1-Year Est. Return
26.23%
This Fund
S&P 500
This Quarter
Est. Return
+14.38%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.74B
AUM Growth
-$52.1M
(-2.9%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
81.62%
Holding
43
New
5
Increased
3
Reduced
12
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
DaVita
DVA
|
+$48.4M |
| 3 |
Recursion Pharmaceuticals
RXRX
|
+$44.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$35.2M |
| 5 |
Affirm
AFRM
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$158M |
| 2 |
Adobe
ADBE
|
+$155M |
| 3 |
Royalty Pharma
RPRX
|
+$152M |
| 4 |
Microsoft
MSFT
|
+$61.7M |
| 5 |
Salesforce
CRM
|
+$34.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.04% |
| 2 | Technology | 25.62% |
| 3 | Consumer Discretionary | 12.12% |
| 4 | Communication Services | 10.39% |
| 5 | Financials | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.89T
| $333M | 19.19% |
+2,434,903
| New | +$315M |
|
|
2
Royalty Pharma
RPRX
$26.1B
| $293M | 16.85% |
7,142,856
-3,571,428
| -33% | -$152M |
|
|
LNW
3
DELISTED
Light & Wonder
LNW
| $207M | 11.94% |
2,678,571
| – | – |
|
|
4
Meta Platforms (Facebook)
META
$1.51T
| $181M | 10.39% |
519,456
+109,761
| +27% | +$35.2M |
|
5
Palo Alto Networks
PANW
$264B
| $91.3M | 5.25% |
1,475,658
-569,742
| -28% | -$33.8M |
|
6
AbCellera Biologics
ABCL
$1.62B
| $90.3M | 5.2% |
4,105,095
| – | – |
|
|
7
Intercontinental Exchange
ICE
$82.4B
| $81.7M | 4.7% |
688,549
-1,373,895
| -67% | -$158M |
|
|
8
Recursion Pharmaceuticals
RXRX
$1.57B
| $55.1M | 3.17% |
+1,509,254
| New | +$44.7M |
|
|
9
DaVita
DVA
$15.1B
| $49.2M | 2.83% |
+408,912
| New | +$48.4M |
|
10
10x Genomics
TXG
$5.87B
| $36.5M | 2.1% |
186,143
+96,667
| +108% | +$17.5M |
|
11
Invesco QQQ Trust
QQQ
$455B
| $36.2M | 2.08% |
102,222
-5,722
| -5% | -$1.92M |
|
|
12
Affirm
AFRM
$23.5B
| $32.2M | 1.85% |
+477,421
| New | +$30.5M |
|
13
iShares Core S&P 500 ETF
IVV
$876B
| $28.1M | 1.62% |
65,342
-174
| -0.3% | -$72.9K |
|
14
PureCycle Technologies
PCT
$1.17B
| $25.3M | 1.46% |
1,069,600
-206,667
| -16% | -$4.45M |
|
15
Revolution Medicines
RVMD
$40.2B
| $21.3M | 1.22% |
670,382
| – | – |
|
16
Unity
U
$12.5B
| $20.5M | 1.18% |
186,396
| – | – |
|
17
Relay Therapeutics
RLAY
$4.02B
| $19.8M | 1.14% |
541,124
| – | – |
|
18
Pliant Therapeutics
PLRX
$67.5M
| $16.4M | 0.94% |
562,379
| – | – |
|
19
SPDR Gold Trust
GLD
$131B
| $15.2M | 0.88% |
91,955
-4,707
| -5% | -$800K |
|
20
Praxis Precision Medicines
PRAX
$9.07B
| $14.2M | 0.82% |
51,901
| – | – |
|
|
GBIO
21
DELISTED
Generation Bio
GBIO
| $13.8M | 0.79% |
51,235
| – | – |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $11.6M | 0.67% |
498,001
| – | – |
|
23
Sana Biotechnology
SANA
$885M
| $9.22M | 0.53% |
468,749
| – | – |
|
24
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $8.38M | 0.48% |
162,699
-13,238
| -8% | -$683K |
|
25
Nurix Therapeutics
NRIX
$2.43B
| $8.35M | 0.48% |
314,762
| – | – |
|
Similar funds
DWT
MCC
ST
DE
SI
WIC
GC
RHJA
Harvard Management Company's Q2 2021 Portfolio in Review
As of Q2 2021, Harvard Management Company held 43 positions worth $1.74B, down 2.9% from $1.79B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Harvard Management Company withdrew a net $131M in Q2 2021, closing 5 positions and reducing 12 holdings. Its most notable exit was Adobe, an estimated $155M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Harvard Management Company opened a new position in Apple worth $333M.
- Harvard Management Company's largest Q2 2021 buy was Apple: 2,434,903 shares worth $333M.
- Harvard Management Company added most to Meta Platforms (Facebook) in Q2 2021, an estimated $35.2M increase.
- Harvard Management Company's biggest Q2 2021 reduction was Intercontinental Exchange, cutting an estimated $158M.
- Harvard Management Company fully exited Adobe in Q2 2021, selling an estimated $155M.
- Harvard Management Company's ten largest holdings make up 82% of its $1.74B portfolio in Q2 2021.
- Harvard Management Company opened 5 new positions and closed 5 in Q2 2021.
- Harvard Management Company's portfolio value fell 2.9% quarter-over-quarter to $1.74B.
Based on Harvard Management Company's 13F filing for Q2 2021, filed 13 Aug 2021.